What to know about FDA panel's meeting Thursday for Pfizer's COVID-19 vaccine
The FDA is providing details about how it plans to proceed Thursday regarding pending approval of Pfizer's COVID-19 vaccine. |!| Kansas City
The FDA is providing details about how it plans to proceed Thursday regarding pending approval of Pfizer's COVID-19 vaccine. |!| Kansas City